|
1
|
Liotta LA: Cancer cell invasion and
metastasis. Sci Am. 266:54–59. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Fidler I: Metastasis: quantitative
analysis of distribution and fate of tumor emboli labeled with
125I-5 iodo-2-deoxyuridine. J Natl Cancer Inst. 45:773–779.
1970.PubMed/NCBI
|
|
3
|
Mehdi AB, Tozawa K, Fisher AB, Shientag L,
Lee A and Muschel RJ: Intravascular origin of metastasis from the
proliferation of endothelium-attached tumor cells: a new model for
metastasis. Nat Med. 6:100–102. 2000. View
Article : Google Scholar : PubMed/NCBI
|
|
4
|
Gorelik E, Wiltrout RH, Okumura K, Habu S
and Herberman RB: Role of NK cells in the control of metastatic
spread and growth of tumor cells in mice. Int J Cancer. 30:107–112.
1982. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Hanna N: The role of natural killer cells
in the control of tumor growth and metastasis. Biochim Biophys
Acta. 780:213–226. 1985.PubMed/NCBI
|
|
6
|
Arnon TI, Achdout H, Lieberman N, Gazit R,
Gonen-Gross T, Katz G, Bar-Ilan A, Bloushtain N, Lev M, Joseph A,
Kedar E, Porgador A and Mandelboim O: The mechanisms controlling
the recognition of tumor- and virus-infected cells by NKp46. Blood.
103:664–672. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Rickles FR and Falanga A: Molecular basis
for the relationship between thrombosis and cancer. Thromb Res.
102:V215–V224. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Terraube V, Pendu R, Baruch D, Gebbink MF,
Meyer D, Lenting PJ and Denis CV: Increased metastatic potential of
tumor cells in von Willebrand factor-deficient mice. J Thromb
Haemost. 4:519–526. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Dvorak HF, Nagy JA, Berse B, Brown LF, Yeo
KT, Yeo TK, Dvorak AM, van de Water L, Sioussat TM and Senger DR:
Vascular permeability factor, fibrin, and the pathogenesis of tumor
stroma formation. Ann N Y Acad Sci. 667:101–111. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Nierodzik ML and Karpatkin S: Thrombin
induces tumor growth, metastasis, and angiogenesis: evidence for a
thrombin-regulated dormant tumor phenotype. Cancer Cell.
10:355–362. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Langer F, Amirkhosravi A, Ingersoll SB,
Walker JM, Spath B, Eifrig B, Bokemeyer C and Francis JL:
Experimental metastasis and primary tumor growth in mice with
hemophilia A. J Thromb Haemost. 4:1056–1062. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Gunji Y, Lewis J and Gorelik E: Fibrin
formation inhibits the in vitro cytotoxic activity of human natural
and lymphokine-activated killer cells. Blood Coagul Fibrinolysis.
1:663–672. 1990.PubMed/NCBI
|
|
13
|
Atagi S, Sone S, Fukuta K and Ogura T:
Inhibition by fibrin coagulation of lung cancer cell destruction by
human interleukin-2-activated killer cells. Jpn J Cancer Res.
83:1088–1094. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Gao Y, Zhou S, Jiang W, Huang M and Dai X:
Effects of ganopoly (a Ganoderma lucidum polysaccharide
extract) on the immune functions in advanced-stage cancer patients.
Immunol Invest. 32:201–215. 2003.PubMed/NCBI
|
|
15
|
Sliva D, Labarrere C, Slivova V, Sedlak M,
Lloyd FP Jr, Ho NW, et al: Ganoderma lucidum suppresses
motility of highly invasive breast and prostate cancer cells.
Biochem Biophys Res Commun. 298:603–612. 2002. View Article : Google Scholar
|
|
16
|
Sliva D: Ganoderma lucidum (Reishi)
in cancer treatment. Integr Cancer Ther. 2:358–364. 2003.
View Article : Google Scholar
|
|
17
|
Zhang Q and Lin Z: Study on antitumour
activity and mechanism of Ganoderma polysaccharides B.
Zhongguo Zhong Xi Yi Jie He Za Zhi. 19:544–547. 1999.PubMed/NCBI
|
|
18
|
Sun LX, Lin ZB, Li XJ, Li M, Lu J, Duan
XS, Ge ZH, Song YX, Xing EH and Li WD: Promoting effects of
Ganoderma lucidum polysaccharides on B16F10 cells to
activate lymphocytes. Basic Clin Pharmacol Toxicol. 108:149–154.
2011.
|
|
19
|
Wu QP, Xie YZ, Li SZ, La Pierre DP, Deng
ZQ, Chen Q, Li C, Zhang Z, Guo J, Wong CKA, Daniel Y, Yee A and
Burton BY: Tumour cell adhesion and integrin expression affected by
Ganoderma lucidum. Enzyme Microb Technol. 40:32–41. 2006.
View Article : Google Scholar
|
|
20
|
Kimura Y, Taniguchi M and Baba K:
Antitumour and antimetastatic effects on liver of triterpenoid
fractions of Ganoderma lucidum: mechanism of action and
isolation of an active substance. Anticancer Res. 22:3309–3318.
2002.PubMed/NCBI
|
